{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:32:57Z","timestamp":1789695177644,"version":"4.0.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272689"],"award-info":[{"award-number":["82272689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-025-00880-1","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:46:10Z","timestamp":1767789970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting YAP1-CD70 axis potentiates the efficacy of anti-PD-1 therapy in prostate cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Tongyu","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"880_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/annonc\/mdy232","volume":"29","author":"AR Hansen","year":"2018","unstructured":"Hansen AR, Massard C, Ott PA, Haas NB, Lopez JS, Ejadi S, et al. Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study. Ann Oncol. 2018;29:1807\u201313.","journal-title":"Ann Oncol"},{"key":"880_CR2","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1002\/cam4.2375","volume":"8","author":"MD Tucker","year":"2019","unstructured":"Tucker MD, Zhu J, Marin D, Gupta RT, Gupta S, Berry WR, et al. Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer. Cancer Med. 2019;8:4644\u201355.","journal-title":"Cancer Med"},{"key":"880_CR3","doi-asserted-by":"publisher","first-page":"101280","DOI":"10.1016\/j.mam.2024.101280","volume":"98","author":"T Tong","year":"2024","unstructured":"Tong T, Huang M, Yan B, Lin B, Yu J, Teng Q, et al. Hippo signaling modulation and its biological implications in urological malignancies. Mol Aspects Med. 2024;98:101280.","journal-title":"Mol Aspects Med"},{"key":"880_CR4","doi-asserted-by":"crossref","unstructured":"Chen X, Fu H, Zhu S, Xiang Z, Fu H, Sun Z, et al. The moonlighting function of Glutamin synthase 2 promotes immune evasion of pancreatic ductal adenocarcinoma by tubulin tyrosine Ligase-like 1-Mediated Yes1 associated transcriptional regulator glutamylation. Gastroenterology. 2025;S0016-5085(25)00357-9.","DOI":"10.1053\/j.gastro.2025.01.240"},{"key":"880_CR5","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1158\/2159-8290.CD-24-0102","volume":"14","author":"SK Pal","year":"2024","unstructured":"Pal SK, Tran B, Haanen JBAG, Hurwitz ME, Sacher A, Tannir NM, et al. CD70-Targeted allogeneic CAR T-Cell therapy for advanced clear cell renal cell carcinoma. Cancer Discov. 2024;14:1176\u201389.","journal-title":"Cancer Discov"},{"key":"880_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2024.01.011","volume":"57","author":"CA Jaeger-Ruckstuhl","year":"2024","unstructured":"Jaeger-Ruckstuhl CA, Lo Y, Fulton E, Waltner OG, Shabaneh TB, Simon S, et al. Signaling via a CD27-TRAF2-SHP-1 axis during Naive T cell activation promotes memory-associated gene regulatory networks. Immunity. 2024;57:287\u2013e30212.","journal-title":"Immunity"},{"key":"880_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40364-022-00365-5","volume":"10","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Mao M, Lu Y. The biology of YAP in programmed cell death. Biomark Res. 2022;10:34.","journal-title":"Biomark Res"},{"key":"880_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03548-0","author":"T Tong","year":"2025","unstructured":"Tong T, Lei H, Huang M, Yang Z, Dai X, Zou H, Guo Y, Luo J, Teng Q, Cao F, Pang J, Li P. HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer. Oncogene. 2025. https:\/\/doi.org\/10.1038\/s41388-025-03548-0.","journal-title":"Oncogene"},{"issue":"1","key":"880_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s12951-025-03607-4","volume":"23","author":"F Cao","year":"2025","unstructured":"Cao F, Xu Y, Guan Y, Zhang K, Qiu H, Xu Z, He Y, Xiao ZX, Zha GF, Pang J. Enhancing the potency of 5T4 mRNA vaccine by CD70 mRNA-LNPs through ADCC and T cell boosting in prostate cancer therapy. J Nanobiotechnol. 2025;23(1):523.","journal-title":"J Nanobiotechnol"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00880-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00880-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00880-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:46:11Z","timestamp":1767789971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-025-00880-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00880-1","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients received written informed consent and all the collections of the PCa samples were approved by Ethics Committee of the Seventh Affiliated Hospital, Sun Yat-sen University (Approval No: [KY-2024-069-02]; Date: [2024.04.26]) with the Declaration of Helsinki. The study was conducted following written and orally informed participant consent. Individual consent for this retrospective analysis was not applicable. For protection of the patient personal data, only anonymized data have been used for the analyses of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agreed for publication of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}